Lataa...
The I-MICRO trial, Ilomedin for treatment of septic shock with persistent microperfusion defects: a double-blind, randomized controlled trial—study protocol for a randomized controlled trial
BACKGROUND: Septic shock remains a significant cause of death in critically ill patients. During septic shock, some patients will retain microcirculatory disorders despite optimal hemodynamic support (i.e., fluid resuscitation, vasopressors, inotropes). Alterations in the microcirculation are a key...
Tallennettuna:
| Julkaisussa: | Trials |
|---|---|
| Päätekijät: | , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7329442/ https://ncbi.nlm.nih.gov/pubmed/32611377 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-020-04549-y |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|